Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Cervical Cancer

  Free Subscription


26.01.2026

1 ACS Appl Mater Interfaces
1 Adv Sci (Weinh)
1 Anal Methods
5 Asian Pac J Cancer Prev
1 Biomed Res Int
1 BJOG
1 BMC Cancer
1 BMC Infect Dis
1 BMC Public Health
1 BMJ Case Rep
1 BMJ Public Health
1 Br J Cancer
1 Cancer
2 Cancer Causes Control
1 Cancer Control
2 Cancer Epidemiol
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Sci
1 Case Rep Womens Health
1 Cell Rep Med
2 Cureus
1 Curr Med Chem
1 Daru
2 Diagn Microbiol Infect Dis
2 Discov Oncol
6 Ecancermedicalscience
4 Front Oncol
1 Front Public Health
1 Gynecol Oncol Rep
1 Health Commun
2 Hum Vaccin Immunother
1 Int Immunopharmacol
1 Int J Clin Oncol
1 Int J Gynaecol Obstet
4 Int J Gynecol Cancer
2 Int J Surg
1 J Biophotonics
1 J Clin Virol
2 J Gynecol Oncol
1 J Pathol
1 J Prim Health Care
1 JCO Glob Oncol
1 JMIR Form Res
2 Lancet Glob Health
1 Med Oncol
1 Medicine (Baltimore)
1 Mol Clin Oncol
1 Nat Commun
1 Obstet Gynecol Surv
1 Oncol Lett
1 Pathologie (Heidelb)
1 PLOS Glob Public Health
2 PLoS One
1 Radiography (Lond)
1 Radiol Phys Technol
1 Reprod Sci
1 Sci Rep
2 Support Care Cancer
1 Toxicol Appl Pharmacol
1 Virol J


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Appl Mater Interfaces

  1. SU Q, Duan H, Li Q, Zhang M, et al
    Galectin-1-Targeted Type-I/II Photosensitizers Activate the NF-kappaB Pathway to Enhance Immunity and Treat High-Risk HPV-Associated Cervical Lesions.
    ACS Appl Mater Interfaces. 2026;18:3599-3614.
    PubMed         Abstract available


    Adv Sci (Weinh)

  2. WANG L, Zhu J, Ding Z, Xie Z, et al
    Immune Predictors of Radiotherapy Outcomes in Cervical Cancer.
    Adv Sci (Weinh). 2026 Jan 21:e09784. doi: 10.1002/advs.202509784.
    PubMed         Abstract available


    Anal Methods

  3. MWAENI V, Nyamai D, Khamadi S, Musenjeri S, et al
    Multimodal detection of high-risk HPV oncogenic transcripts using a branched hybridization chain reaction amplification method.
    Anal Methods. 2026;18:293-305.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  4. GEORGA D, Saridi M, Rouka E, Fradelos EE, et al
    Exploring Women's Attitudes Towards Cervical Cancer Screening and Their Association with Life Satisfaction and General Life Attitudes: A Systematic Review.
    Asian Pac J Cancer Prev. 2026;27:37-46.
    PubMed         Abstract available

  5. LATTASAKSIRI P, Prasongvej P, Chanthasenanont A, Boriboonhirunsarn D, et al
    Knowledge and Attitudes of Pregnant Women toward Cervical Cancer Screening during Pregnancy.
    Asian Pac J Cancer Prev. 2026;27:117-121.
    PubMed         Abstract available

  6. MOHD NAFIS NS, Mat Zin AA, Ab Hamid SA
    Assessment of Pathtezt(R) Infinity Processor and Autoloader Efficiency in Cervical Smear Analysis.
    Asian Pac J Cancer Prev. 2026;27:193-199.
    PubMed         Abstract available

  7. HANGA AH, Amin S, Iqbal A, Shah A, et al
    Between Belief and Biology: Cervical Cancer's Occurrence and Health Literacy among India's Muslim Women.
    Asian Pac J Cancer Prev. 2026;27:219-226.
    PubMed         Abstract available

  8. HARADA I, Ito Y, Morita K, Kawahara M, et al
    Associations Between Regional Factors and Cervical Cancer Screening Coverage in Tokyo.
    Asian Pac J Cancer Prev. 2026;27:281-285.
    PubMed         Abstract available


    Biomed Res Int

  9. ENYAN NIE, Zhang M, Ken-Amoah S, King-Okoye M, et al
    Acceptance of HPV Vaccination: A Systematic Review of Knowledge, Attitudes and Barriers Among Healthcare Practitioners in Low- and Middle-Income Countries.
    Biomed Res Int. 2026;2026:9294978.
    PubMed         Abstract available


    BJOG

  10. XIE H, Li J, Huang H, Emmanuel A, et al
    SOX1/PAX1 Methylation for Triage of HPV-Positive Women in Cervical Cancer Screening: A Cohort Study.
    BJOG. 2026 Jan 19. doi: 10.1111/1471-0528.70162.
    PubMed         Abstract available


    BMC Cancer

  11. GUO W, Jian W, Zhu L, Zhang B, et al
    3D transformer-based dose prediction in HDR brachytherapy for cervical cancer.
    BMC Cancer. 2026 Jan 20. doi: 10.1186/s12885-026-15592.
    PubMed        


    BMC Infect Dis

  12. IZQUIERDO-CONDOY JS, Torres PL, Galarza MO, Salinas KA, et al
    Prevalence and age-related trends of high-risk Human Papillomavirus genomes in Ecuadorian women: a comprehensive cross-sectional study.
    BMC Infect Dis. 2025;26:83.
    PubMed         Abstract available


    BMC Public Health

  13. LI Y, Xin R, Chai P, Liu B, et al
    Economic evidence for expansion of HPV vaccination for the prevention of cervical cancer in LMICs: BIA framework construction and empirical analysis in China.
    BMC Public Health. 2026 Jan 19. doi: 10.1186/s12889-026-26216.
    PubMed        


    BMJ Case Rep

  14. WONG SIAW LIN C, Ghosh A, Bhardwaj N, Zouridis A, et al
    Concomitant low-grade B-cell lymphoma and cervical intraepithelial neoplasia.
    BMJ Case Rep. 2026;19:e270886.
    PubMed         Abstract available


    BMJ Public Health

  15. WEBB S, Mat Ali N, Augustin Y, Hayward SE, et al
    Understanding knowledge, beliefs, values and barriers towards cervical cancer screening and self-sampling amongst migrant Muslim women in Southwest London: an in-depth qualitative interview study.
    BMJ Public Health. 2026;4:e003254.
    PubMed         Abstract available


    Br J Cancer

  16. BOWDEN SJ, Ellis LB, Cuming T, Brogden D, et al
    Multizonal intraepithelial neoplasia of the lower genital tract and anus in women: terminology for defining the disease, an introduction by the British Society for Colposcopy and Cervical Pathology (BSCCP), International Anal Neoplasia Society (IANS),
    Br J Cancer. 2026;134:177-184.
    PubMed         Abstract available


    Cancer

  17. LAWRENCE L
    Adjuvant chemoradiation offers minimal survival improvements over radiation alone in intermediate-risk, early cervical cancer: Chemoradiation has become the standard of care for patients with locally advanced cervical cancer as well as high-risk featu
    Cancer. 2026;132:e70207.
    PubMed        


    Cancer Causes Control

  18. AL-MUTAIRI SH, Akhtar S
    Age at first marriage, menopause status and cervical cancer risk in a middle eastern country: a national cancer registry-based case-control study.
    Cancer Causes Control. 2026;37:18.
    PubMed         Abstract available

  19. OOMMEN AM, Ashfaq M, Ranjani DP, Suresh D, et al
    Leveraging the role of families in decision-making to inform a program of HPV-based self-collection for cervical screening in Tamil Nadu, India: a qualitative study.
    Cancer Causes Control. 2026;37:25.
    PubMed         Abstract available


    Cancer Control

  20. NAMUTUNDU J, Nakku-Joloba E, Kiguli J, Makumbi F, et al
    "Correcting Misinformation is Challenging": Exploring Barriers and Facilitators of Health Care Providers' Responsiveness to Cervical Cancer Screening Literacy Needs of Rural Women Living With HIV in Eastern Uganda.
    Cancer Control. 2026;33:10732748261419591.
    PubMed         Abstract available


    Cancer Epidemiol

  21. AKALIN K, Cicek Gumus E, Dolu I
    Cancer screening knowledge and health literacy among rural women Aged 30-69.
    Cancer Epidemiol. 2026;100:102971.
    PubMed         Abstract available

  22. NGUANBOONMAK A, Pakkaranang B, Yanaranop M, Tantiyavarong P, et al
    Incidence trends and survival of cervical cancer: A population-based study on Thai Cancer registry database.
    Cancer Epidemiol. 2026;101:102992.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  23. AHMED B, Sayeed S, Rhodes C, Shahab G, et al
    The Virginia Commonwealth University Cervical Cytology Biorepository: A Protocol for Advancing Translational Cervical Cancer Research through Biobanking.
    Cancer Epidemiol Biomarkers Prev. 2026.
    PubMed         Abstract available


    Cancer Sci

  24. GAO M, Cui Z, Song H, Li Y, et al
    IRF4 Enhances Radiosensitivity of Cervical Cancer by Inhibiting the PI3K/Akt/mTOR Pathway to Regulate Autophagy.
    Cancer Sci. 2026 Jan 19. doi: 10.1111/cas.70305.
    PubMed         Abstract available


    Case Rep Womens Health

  25. YAMAZAWA Y, Iijima T, Shigenaga D, Cho T, et al
    Rapid enlargement of a tubo-ovarian abscess in a patient with cervical cancer and multiple uterine fibroids: A case report.
    Case Rep Womens Health. 2026;49:e00784.
    PubMed         Abstract available


    Cell Rep Med

  26. JIANG H, Cai J, Shen Z, Xu M, et al
    UniCAS: A foundation model for cervical cytology screening.
    Cell Rep Med. 2026;7:102570.
    PubMed         Abstract available


    Cureus

  27. AHMED AE, Hatan WM, Alrehaili SE, Alghamdi WR, et al
    Interventions in Primary Care to Improve Cervical Cancer Screening: A Systematic Review.
    Cureus. 2025;17:e99604.
    PubMed         Abstract available

  28. MUTUA F, Dube S, Shrivastav A, Kakumanu S, et al
    Cervical Cancer Outcomes and Toxicity in HIV-Positive Women Treated With Radiation or Chemoradiation: A Systematic Review.
    Cureus. 2025;17:e99855.
    PubMed         Abstract available


    Curr Med Chem

  29. JIANG R, Zheng J, Lin X, Wang S, et al
    EGF Family-Based Prognostic Model Reveals AREG as a Key Regulator in Cervical Cancer Progression.
    Curr Med Chem. 2026 Jan 9. doi: 10.2174/0109298673397451251105070115.
    PubMed         Abstract available


    Daru

  30. TIMALSINA G, Parida BP, Radhakrishnan M, Khoiyang T, et al
    Falcarindiol induces apoptosis, ROS accumulation, and cell cycle arrest via EGFR/mTOR pathway modulation: an integrated in silico and in vitro study in cervical cancer.
    Daru. 2026;34:7.
    PubMed         Abstract available


    Diagn Microbiol Infect Dis

  31. CHIN T, Ostrbenk A, Verhavert N, Poljak M, et al
    Multi-centre clinical validation of the NeuMoDx HPV assay for ASC-US / LSIL triage.
    Diagn Microbiol Infect Dis. 2026;114:117208.
    PubMed         Abstract available

  32. MADHAVAN Y, Muthukumar V, Ramasubramanian S, Ramshankar V, et al
    High throughput HPV genotyping by next generation sequencing for detection of 28 HPV types and 13 sexually transmitted infections: A first community-based cervical cancer screening study from India.
    Diagn Microbiol Infect Dis. 2026;114:117278.
    PubMed         Abstract available


    Discov Oncol

  33. HUANG Z, Luo Y, Gao Q, Wang L, et al
    Novel N(6)-methyladenosine (m(6)A) writer METTL16 promotes the cervical cancer tumorigenesis by targeting FTH1-dependent ferroptosis.
    Discov Oncol. 2026 Jan 20. doi: 10.1007/s12672-026-04403.
    PubMed         Abstract available

  34. ZHANG YJ, Yan L, Chen YY, Jiang X, et al
    A nomogram-based prediction model for assessing the risk of vain and stump cancer recurrence following radical surgery for cervical cancer.
    Discov Oncol. 2026 Jan 21. doi: 10.1007/s12672-026-04462.
    PubMed        


    Ecancermedicalscience

  35. OLAYIWOLA AA, Oshodi YA, Akinola OI, Banjo AA, et al
    High-risk HPV serotype distribution in cervical cancer: comparative analysis of detection in cervicovaginal secretions and tissue DNA extraction.
    Ecancermedicalscience. 2025;19:1992.
    PubMed         Abstract available

  36. ADENEKAN MA, Minari JB, Adefemi A, Olorunfemi G, et al
    Comparison analysis of serum interleukin-6 levels and cervical cancer.
    Ecancermedicalscience. 2025;19:2009.
    PubMed         Abstract available

  37. CHHABRA M, Meet S, Tendulkar G, Oswal K, et al
    Barriers to screening of breast and cervical cancer among women in remote villages of Karnataka: an analysis using the Health Belief Model.
    Ecancermedicalscience. 2025;19:1980.
    PubMed         Abstract available

  38. SAMIA K, Yassine B, Mehdi SE, Wissal H, et al
    Psychosocial impact of cervical cancer diagnosis: a study conducted in the Radiotherapy Department at CHU Hassan II, Fez, Morocco.
    Ecancermedicalscience. 2025;19:1976.
    PubMed         Abstract available

  39. KIBUDDE S, Kavuma A, Abal B, Katumba MF, et al
    Radiation therapy for cervical cancer in Uganda: a practice guideline.
    Ecancermedicalscience. 2025;19:1999.
    PubMed         Abstract available

  40. AKISEKU AK, Adenuga TO, Jagun OE, Popoola MA, et al
    Individual-level determinants of late-stage cervical cancer diagnosis and their implications for prevention and control.
    Ecancermedicalscience. 2025;19:2008.
    PubMed         Abstract available


    Front Oncol

  41. YI K, Zhang J, Wang H, Chen P, et al
    Utility of extended HPV genotyping in cervical cancer screening: a prospective population-based cohort study in China.
    Front Oncol. 2026;15:1754438.
    PubMed         Abstract available

  42. YANG H, Xu F, Liu Y, Chen Q, et al
    Pelvic artery embolization versus vaginal packing for controlling vaginal bleeding in locally advanced cervical cancer: a retrospective cohort study from a tertiary cancer center in Xinjiang, China.
    Front Oncol. 2026;15:1711701.
    PubMed         Abstract available

  43. DING L, Li S, Jin Z, Yao C, et al
    The impact of body composition and systemic inflammatory markers on postoperative complications in early-stage cervical cancer.
    Front Oncol. 2026;15:1696383.
    PubMed         Abstract available

  44. BASERA A, Alaouna M, Duvenhage J, Bates DO, et al
    HPV-driven transcriptome and splicing rewiring under SRPK1 inhibition in cervical cancer.
    Front Oncol. 2026;15:1712170.
    PubMed         Abstract available


    Front Public Health

  45. WANG W, Zhang J, Mei C, Dai Q, et al
    Prevalence and genotype distribution of human papillomavirus infection among women in Chengdu, China between 2020 and 2024.
    Front Public Health. 2026;13:1740177.
    PubMed         Abstract available


    Gynecol Oncol Rep

  46. GROSS M, Wang JY, Goff BA, Ma TM, et al
    Treatment delay and prolongation in locally advanced cervical cancer.
    Gynecol Oncol Rep. 2025;63:102004.
    PubMed         Abstract available


    Health Commun

  47. KIRKPATRICK CE, Lawrie LL
    "This is What a Speculum Looks Like!" Effects of Medical Instrument Demonstration and Message Framing in Pap Test Videos on Social Media.
    Health Commun. 2026;41:278-289.
    PubMed         Abstract available


    Hum Vaccin Immunother

  48. KOIVISTO T, Eriksson T, Hokkanen M, Apter D, et al
    Human papillomavirus vaccinations' association to childbirth rates.
    Hum Vaccin Immunother. 2026;22:2598691.
    PubMed         Abstract available

  49. FOKOM DOMGUE J, Al-Antary N, Gerend MA, Nair M, et al
    Awareness of the link between HPV and cancer according to cancer type and gender in the US from 2014-2020.
    Hum Vaccin Immunother. 2026;22:2610894.
    PubMed         Abstract available


    Int Immunopharmacol

  50. JIA H, Arifu A, Wang J, Fan P, et al
    SPP1 enhances radiotherapy resistance through CCL2-mediated M2-like polarization of macrophages in cervical Cancer.
    Int Immunopharmacol. 2026;172:116119.
    PubMed         Abstract available


    Int J Clin Oncol

  51. SATO S, Kagabu M, Jo A, Otsuka H, et al
    Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancer.
    Int J Clin Oncol. 2026 Jan 22. doi: 10.1007/s10147-026-02960.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  52. MUSA MS, Swai P, Oneko O, Mmbaga B, et al
    Three-year survival rate and associated factors among women with invasive cervical cancer attended at ocean road cancer institute, Tanzania.
    Int J Gynaecol Obstet. 2026 Jan 22. doi: 10.1002/ijgo.70831.
    PubMed         Abstract available


    Int J Gynecol Cancer

  53. PENG R, Wu Q, Qiu X
    Correspondence on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study"(1) by Mascilini et al.
    Int J Gynecol Cancer. 2026 Jan 3:104459. doi: 10.1016/j.ijgc.2025.104459.
    PubMed        

  54. CHU R, Wang Z, Shi S, Wu N, et al
    Histology-specific prognostic models for early-stage cervical cancer based on pathologic intermediate-risk factors: a multi-center retrospective study.
    Int J Gynecol Cancer. 2026;36:104465.
    PubMed         Abstract available

  55. CHILINDA G, Moro F, Rijken MJ, Ciancia M, et al
    Ultrasound-based preoperative assessment for cervical cancer: a pragmatic staging and treatment-planning strategy adaptable to diverse resource settings.
    Int J Gynecol Cancer. 2025;36:102885.
    PubMed         Abstract available

  56. HSU HN, Lin YH
    Pembrolizumab-induced vasculitis-like dermatitis in cervical cancer.
    Int J Gynecol Cancer. 2025 Dec 22:104445. doi: 10.1016/j.ijgc.2025.104445.
    PubMed        


    Int J Surg

  57. ZHANG J, Wei W
    Re-examining the lymph node surgical strategies for small-cell cervical cancer: shifting from local intervention to a systemic paradigm.
    Int J Surg. 2026 Jan 20. doi: 10.1097/JS9.0000000000004649.
    PubMed        

  58. YANG XL, Zhu JW, Zhou YC, You Y, et al
    Appraisal the significance of completion hysterectomy after definitive concurrent chemoradiotherapy for patients with locally advanced cervical adenocarcinoma: the ATTRACT study.
    Int J Surg. 2026;112:1274-1283.
    PubMed         Abstract available


    J Biophotonics

  59. SAHOO GR, Sah AN, Srivastava M, Panigrahi PK, et al
    In Vivo Cervical Precancer Classification Through Multifractal Analysis of Spectral Fluctuations in Intrinsic Fluorescence Spectra.
    J Biophotonics. 2026;19:e202500282.
    PubMed         Abstract available


    J Clin Virol

  60. ALMAS S, Karki S, Carpenter RE, Tamrakar VK, et al
    Peptide-assisted direct detection of HPV nucleic acids from liquid-based cytology samples without extraction.
    J Clin Virol. 2026;182:105901.
    PubMed         Abstract available


    J Gynecol Oncol

  61. KIM U, Bae J, Paik ES, Lim MC, et al
    Prognostic value and adjuvant treatment outcomes for the use of the JGOG prognostic model in early-stage intermediate-risk cervical cancer: a Korean Gynecologic Oncology Group study (KGOG 1028).
    J Gynecol Oncol. 2026 Jan 8. doi: 10.3802/jgo.2026.
    PubMed         Abstract available

  62. KIM J, Jang J, Kang S
    Patient-centered valuation of minimally invasive surgery in cervical cancer: a discrete choice experiment.
    J Gynecol Oncol. 2025 Dec 29. doi: 10.3802/jgo.2026.
    PubMed         Abstract available


    J Pathol

  63. CHARBEL A, Akiki G, Diwan SS, Leung SOA, et al
    Small cell neuroendocrine carcinoma of the cervix: diagnostic challenges and emerging molecular insights(dagger).
    J Pathol. 2026;268:123-126.
    PubMed         Abstract available


    J Prim Health Care

  64. SPARKES NK, Adcock A, Slater T, MacDonald EJ, et al
    'Point-of-Care-Testing is definitely the way to go': primary healthcare professionals in rural Aotearoa New Zealand talk about point-of-care testing for cervical cancer prevention.
    J Prim Health Care. 2026 Jan 22. doi: 10.1071/HC25164.
    PubMed         Abstract available


    JCO Glob Oncol

  65. GROVER S, Chambers A, Azoba C, Bhatia RK, et al
    Overcoming Logistical Barriers to Conducting Collaborative Clinical Research Between a High-Income Country and a Low- and Middle-Income Country.
    JCO Glob Oncol. 2026;12:e2400534.
    PubMed         Abstract available


    JMIR Form Res

  66. BABATUNDE AO, Kokelu E, Olusanya OA, Kalulu P, et al
    Creative Arts to Enhance Cervical Cancer Awareness Using Art-Based Messages From a Nigerian Crowdsourcing Open Call: Qualitative Thematic Analysis.
    JMIR Form Res. 2026;10:e76240.
    PubMed         Abstract available


    Lancet Glob Health

  67. AMANI A, Bloem P, Kobayashi E, Atuhaire B, et al
    Understanding the WHO global strategy to accelerate cervical cancer elimination - Authors' reply.
    Lancet Glob Health. 2026 Jan 16:S2214-109X(26)00011.
    PubMed        

  68. FOKOM DEFO V, Fokom Domgue J
    Understanding the WHO global strategy to accelerate cervical cancer elimination.
    Lancet Glob Health. 2026 Jan 16:S2214-109X(26)00004.
    PubMed        


    Med Oncol

  69. PEI Y, Zhong Z, Li H, Tan Y, et al
    Targeting thymidylate synthase enhances CD8 + T-cell infiltration and inhibits tumor growth in cervical cancer.
    Med Oncol. 2026;43:120.
    PubMed         Abstract available


    Medicine (Baltimore)

  70. ZHANG Y, Meng Y, Shi H, Li L, et al
    Prevalence and influencing factors of depressive and anxiety symptoms in cervical cancer patients during the peri-chemoradiotherapy period: A systematic review meta-analysis.
    Medicine (Baltimore). 2026;105:e47023.
    PubMed         Abstract available


    Mol Clin Oncol

  71. BAO T, Li X, Li W, Yang R, et al
    Integrated multi-omics profiling of plasma extracellular vesicles reveals the hsa-miR-1-3p-LRP1 axis as a potential biomarker in cervical cancer.
    Mol Clin Oncol. 2025;24:13.
    PubMed         Abstract available


    Nat Commun

  72. RAY-COQUARD I, Kaminsky-Forrett MC, Ohkuma R, de Montfort A, et al
    Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial.
    Nat Commun. 2026;17:922.
    PubMed         Abstract available


    Obstet Gynecol Surv

  73. CHANG Y, Li T, Zhou Q, Kang D, et al
    Effectiveness of Artificial Intelligence-Assisted Colposcopy in a Resource-Limited Population.
    Obstet Gynecol Surv. 2026;81:24-25.
    PubMed         Abstract available


    Oncol Lett

  74. CAI X, Lu X, Yang J, Wei X, et al
    Diagnostic value of magnetic resonance imaging in preoperative evaluation of cervical cancer and analysis of pathological features.
    Oncol Lett. 2026;31:96.
    PubMed         Abstract available


    Pathologie (Heidelb)

  75. STOLNICU S
    Role of human papillomavirus status in the classification, diagnosis, and prognosis of malignant cervical epithelial tumors and precursor lesions.
    Pathologie (Heidelb). 2026;47.
    PubMed         Abstract available


    PLOS Glob Public Health

  76. SAPKOTA A, Adhikari C, Kaphle HP, Bist BB, et al
    Effectiveness of health education interventions for cervical cancer screening: A quasi-experimental study in Pokhara Metropolitan Slum, Nepal.
    PLOS Glob Public Health. 2026;6:e0005853.
    PubMed         Abstract available


    PLoS One

  77. WANZALA J, Anino CO
    Uptake of cervical cancer screening and its associated factors among women of reproductive age in Kericho County.
    PLoS One. 2026;21:e0328614.
    PubMed         Abstract available

  78. PROIETTI A, De Angelis E, Buccini L, Leopizzi M, et al
    A pilot multimodal study of cervical cancer: Raman spectroscopy as a molecular fingerprint tool.
    PLoS One. 2026;21:e0327286.
    PubMed         Abstract available


    Radiography (Lond)

  79. LIN X, Piao Z, Huang X, Huang H, et al
    Inter-fraction target and OARs reproducibility in cervical cancer: Influence of immobilization systems and patient positioning verified by daily fan beam CT.
    Radiography (Lond). 2026;32:103328.
    PubMed         Abstract available


    Radiol Phys Technol

  80. INOUE T, Iijima K, Takatsu J, Murakami N, et al
    Impact of the locking function of hybrid inverse planning optimization on the treatment plan quality of intracavitary/interstitial brachytherapy for locally advanced cervical cancer.
    Radiol Phys Technol. 2026 Jan 20. doi: 10.1007/s12194-026-01007.
    PubMed         Abstract available


    Reprod Sci

  81. ZOU D, Wu X, Xin X, Xu T, et al
    Correction to: Construction and Validation of a Novel Prognostic Model Based on Cervical Cancer-Related Genes.
    Reprod Sci. 2026 Jan 21. doi: 10.1007/s43032-026-02053.
    PubMed        


    Sci Rep

  82. LU Q, Li J, Gao X, Wu B, et al
    Folic acid inhibits the Wnt/beta-catenin pathway by upregulating DKK3 to exert anti-tumor effects in cervical squamous cell carcinoma.
    Sci Rep. 2025;16:2930.
    PubMed         Abstract available


    Support Care Cancer

  83. SHAN X, Si J, Qian M, Chen X, et al
    Revealing relationships: The role of self-disclosure and marital intimacy in the post-traumatic growth of cervical cancer patients-A qualitative study.
    Support Care Cancer. 2026;34:121.
    PubMed         Abstract available

  84. CIHAN E, Pirincci CS
    The efficacy of complex decongestive therapy in the treatment of lymphedema associated with endometrial and cervical cancer: evaluation of sensation and balance.
    Support Care Cancer. 2026;34:113.
    PubMed         Abstract available


    Toxicol Appl Pharmacol

  85. ZHANG Y, Zhang Y, Wang K
    EP300 promotes cervical cancer progression through a Wnt/beta-catenin-dependent HIF-1alpha signaling axis.
    Toxicol Appl Pharmacol. 2026 Jan 19:117718. doi: 10.1016/j.taap.2026.117718.
    PubMed         Abstract available


    Virol J

  86. LI J, Huang CB, Zhao F, Zhao DD, et al
    Factors related to cervicogenital high-risk human papillomavirus persistence among Chinese women: a nationwide multi-center cohort study.
    Virol J. 2025;23:13.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.